Cloud Banner

Healthcare

Image

Global Direct-to-Consumer (DTC) Genetic Testing Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Direct-to-Consumer (DTC) Genetic Testing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 12.15% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1550.51 Million
Diagram Market Size (Forecast Year) USD 3880.35 Million
Diagram CAGR 12.15%

Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office)) - Industry Trends and Forecast to 2030.

Direct-to-Consumer (DTC) Genetic Testing Market

Direct-to-Consumer (DTC) Genetic Testing Market Analysis and Size

Direct-to-consumer (DTC) testing can also be known as direct access testing, which allows customers to order laboratory tests directly from a laboratory without necessarily having to work with their healthcare provider. Major factors that are expected to boost the growth of the direct-to-consumer (DTC) genetic testing market in the forecast period are the rise in public alertness. Furthermore, the increase in the income level in the advancing countries is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market.

Data Bridge Market Research analyses that the Direct-to-consumer (DTC) genetic testing market was valued at USD 1,550.51 million in 2022 and is further estimated to reach USD 3,880.35 million by 2030, and is expected to grow at a CAGR of 12.15% during the forecast period of 2023 to 2030. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Direct-to-Consumer (DTC) Genetic Testing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, utrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

EasyDNA (U.S.), Ancestry (U.S.), 23andMe, Inc. (U.S.), Color Health, Inc.(U.S.), Genesis HealthCare (U.S.), Full Genomes Corporation, Inc.(U.S.), Helix OpCo LLC (U.S.), Living DNA Ltd (U.K.), Mapmygenome (India), GenomeWeb (U.S.), Gene by Gene, Ltd. (U.S.), MyHeritage Ltd. (Israel), 10x Genomics (U.S.), Dante Labs, Inc. (U.S.), 24Genetics (Spain), Laboratory Corporation of America Holdings (U.S.), Myriad Genetics, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.) and Uniogen Oy (turkey), among other

Market Opportunities

  • Increasing public awareness of DTC genetic testing is expected to increase its adoption
  • Dramatic rise in the incidence of genetic disorders such as cystic Haemophilia, Alzheimer's disease, sickle cell disease, and some other cancers is anticipated to increase the demand for DTC genetic tests
  • Geographic expansion has significant growth potential in untapped geographical regions for the market

Market Definition

The global direct-to-consumer (DTC) genetic testing market refers to markets where genetic testing services and products are sold directly to consumers without the involvement of medical professionals or intermediaries. DTC genetic testing allows individuals to access their genetic information and analyze it for a variety of purposes, including ancestry tracing, health risk assessment, and personalized medicine. This market includes companies that provide genetic testing kits, online test ordering and result interpretation platforms, and related services.

Direct-to-Consumer (DTC) Genetic Testing Market Dynamics

Drivers

  • Increasing Consumer Awareness

Growing public awareness of the benefits of genetic testing, including ancestry, disease risk assessment, and personalized healthcare insights, has increased the demand for DTC genetic testing. Consumers are becoming more proactive about their health and want convenient and accessible ways to obtain genetic information.

  • Rising Technological Advancements

Advances in gene sequencing technology and bioinformatics have greatly reduced the cost and time required for genetic testing. Technological advancements have led to a significant reduction in the cost of genetic testing. The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has enabled the analysis of multiple genes or even entire genomes at a fraction of the cost compared to traditional methods.

  • Growing Personalized Healthcare and Wellness Trends

The rise in focus on personalized healthcare and wellness, the demand for DTC genetic testing is increasing. Consumers are increasingly interested in understanding their genetic makeup to make informed decisions about their lifestyle, disease prevention, and treatment options. DTC genetic testing provides individuals with valuable insight into their unique genetic profile, enabling a personalized health approach.

Opportunity

  • Rapid Expansion of Test Offerings

DTC genetic testing companies have an opportunity to diversify their testing portfolio and expand beyond parenthood and basic health-related testing. Companies are offering a wider range of genetic tests, including pharmacogenomics, nutrigenomics and carrier screening. Companies can target a wider audience and provide more comprehensive genetic insights. This will act as an opportunity for market growth.

  • Increasing Partnerships with Healthcare Providers

Continued collaboration between DTC genetic testing companies and healthcare providers creates an opportunity for a more integrated and holistic approach to genetic testing. Partnering with medical institutions, DTC companies can leverage their expertise and build trust to ensure responsible use and interpretation of genetic data.

Restraints

  • Lack of Data Privacy and Ethical Concerns

The DTC genetic testing market faces challenges related to data protection and the responsible use of genetic information. Genetic testing involves the collection and analysis of personal genomic data, which raises ethical and privacy concerns. Consumers may have reservations about sharing their genetic information with companies due to potential risks of unauthorized access, data breaches, or misuse of information. These concerns can limit market growth as individuals prioritize the security and privacy of their genetic data.

Challenges

  • Strict Regulatory Landscape

The DTC genetic testing market operates in a complex regulatory environment. Different countries have different regulations and guidelines regarding genetic testing, data protection and the involvement of health professionals. Adapting to changing regulatory requirements and maintaining compliance can be a significant challenge for companies operating in this market.

This direct-to-consumer (DTC) genetic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the direct-to-consumer (DTC) genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In March 2021, 23andMe announced its plans to go public through a merger with a special purpose acquisition company (SPAC) called VG Acquisition Corp. The merger aimed to accelerate the company's growth and expand its consumer health offerings
  • In February 2021, MyHeritage, a leading genealogy and genetic testing company, introduced a new product called MyHeritage Health. It combined genetic testing with family history research to provide users with a comprehensive understanding of their health risks and genetic heritage.

Global Direct-to-Consumer (DTC) Genetic Testing Market Scope

The global Direct-to-Consumer (DTC) Genetic Testing Market is segmented into seven notable segments based on service, test type, technology, product type, business model, end user, and sales channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Service

  • Diagnostic screening
  • Prenatal
  • New-born screening
  • Pre-implantation diagnosis
  • Relationship testing

Test Type

  • Carrier testing
  • Predictive testing
  • Ancestry and relationship testing
  • Nutrigenomics testing and others

Technology

  • Targeted analysis
  • Single nucleotide polymorphism (SNP) chips
  • Whole genome sequencing (WGS)

Product Type

  • Ancestry
  • Health and wellness
  • Entertainment

Business Model

  • Genome data bank material model
  • Individual health planning model
  • Comprehensive genome tests model
  • Medical precision tests model
  • Restricted trait tests model

End User

  • Laboratories
  • Blood banks
  • Nursing homes
  • Hospitals
  • Imaging centers
  • Home care
  • Cosmetics
  • Others

Sales Channel

  • Online sales
  • OTC sales
  • Doctor's office

Global Direct-to-Consumer (DTC) Genetic Testing Market Regional Analysis/Insights

The global direct-to-consumer (DTC) genetic testing market is analyzed, and market size insights and trends are provided based on service, test type, technology, product type, business model, end user and sales channel.

The countries covered in this global direct-to-consumer (DTC) genetic testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the direct-to-consumer (DTC) genetic testing market due to the shift in the outlook of consumers toward genetic testing. Furthermore, the rise in expenditure will further boost the growth of the direct-to-consumer (DTC) genetic testing market in the region during the forecast period.

 Asia-Pacific is projected to observe a significant amount of growth in the direct-to-consumer (DTC) genetic testing market due to the rise in health care awareness. Moreover, the increase in disposable income is further anticipated to propel the growth of the direct-to-consumer (DTC) genetic testing market in the region in the coming years.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The direct-to-consumer (DTC) genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the direct-to-consumer (DTC) genetic testing market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the direct-to-consumer (DTC) genetic testing market. The data is available for the historic period 2015-2020.

Competitive Landscape and Direct-to-consumer (DTC) Genetic Testing Market Share Analysis

The Direct-to-Consumer (DTC) Genetic Testing Market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the direct-to-consumer (DTC) genetic testing market.

Some of the major players operating in the global direct-to-consumer (DTC) genetic testing market are:

  • EasyDNA (U.S.)
  • Ancestry (U.S.)
  • 23andMe, Inc. (U.S.)
  • Color Health, Inc.(U.S.)
  • Genesis HealthCare (U.S.)
  • Full Genomes Corporation, Inc.(U.S.)
  • Helix OpCo LLC (U.S.)
  • Living DNA Ltd (U.K.)
  • Mapmygenome (India)
  • GenomeWeb (U.S.)
  • Gene by Gene, Ltd. (U.S.)
  • MyHeritage Ltd. (Israel)
  • 10x Genomics (U.S.)
  • Dante Labs, Inc. (U.S.)
  • 24Genetics (Spain)
  • Laboratory Corporation of America Holdings (U.S.)
  • Myriad Genetics, Inc. (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • Uniogen Oy (turkey)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Direct-to-Consumer (DTC) Genetic Testing Market will be worth USD 3,880.35 million by 2030.
The Direct-to-Consumer (DTC) Genetic Testing MarketGrowth Rate is 12.15% during the forecast period.
The Increasing Consumer Awareness, Rising Technological Advancements, and Growing Personalized Healthcare and Wellness Trends are the Growth Drivers of the Direct-to-Consumer (DTC) Genetic Testing Market.
The service, test type, technology, product type, business model, end user, and sales channel are the factors on which the Direct-to-Consumer (DTC) Genetic Testing Market research is based.
The MyHeritage, a leading genealogy and genetic testing company, introduced a new product called MyHeritage Health and 23andMe announced its plans to go public through a merger with a special purpose acquisition company (SPAC) called VG Acquisition Corp are the latest developments in the Direct-to-Consumer (DTC) Genetic Testing Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials